These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 22280836)
21. Extracellular Vesicles Released from Alvarez-Jiménez VD; Leyva-Paredes K; García-Martínez M; Vázquez-Flores L; García-Paredes VG; Campillo-Navarro M; Romo-Cruz I; Rosales-García VH; Castañeda-Casimiro J; González-Pozos S; Hernández JM; Wong-Baeza C; García-Pérez BE; Ortiz-Navarrete V; Estrada-Parra S; Serafín-López J; Wong-Baeza I; Chacón-Salinas R; Estrada-García I Front Immunol; 2018; 9():272. PubMed ID: 29520273 [TBL] [Abstract][Full Text] [Related]
22. High Glucose and Carbonyl Stress Impair HIF-1-Regulated Responses and the Control of Mycobacterium tuberculosis in Macrophages. Terán G; Li H; Catrina SB; Liu R; Brighenti S; Zheng X; Grünler J; Nylén S; Carow B; Rottenberg ME mBio; 2022 Oct; 13(5):e0108622. PubMed ID: 36121152 [TBL] [Abstract][Full Text] [Related]
23. Isocitrate lyase from Mycobacterium tuberculosis promotes survival of Mycobacterium smegmatis within macrophage by suppressing cell apoptosis. Li JM; Li N; Zhu DY; Wan LG; He YL; Yang C Chin Med J (Engl); 2008 Jun; 121(12):1114-9. PubMed ID: 18706230 [TBL] [Abstract][Full Text] [Related]
24. Transcriptional landscape of Mycobacterium tuberculosis infection in macrophages. Roy S; Schmeier S; Kaczkowski B; Arner E; Alam T; Ozturk M; Tamgue O; Parihar SP; Kawaji H; Itoh M; Lassmann T; Carninci P; Hayashizaki Y; Forrest ARR; Guler R; Bajic VB; Brombacher F; Suzuki H Sci Rep; 2018 Apr; 8(1):6758. PubMed ID: 29712924 [TBL] [Abstract][Full Text] [Related]
26. Natural and trained innate immunity against Mycobacterium tuberculosis. Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788 [TBL] [Abstract][Full Text] [Related]
27. Polarization of Human Monocyte-Derived Cells With Vitamin D Promotes Control of Rao Muvva J; Parasa VR; Lerm M; Svensson M; Brighenti S Front Immunol; 2019; 10():3157. PubMed ID: 32038652 [No Abstract] [Full Text] [Related]
28. Immunometabolism of Phagocytes During Kumar R; Singh P; Kolloli A; Shi L; Bushkin Y; Tyagi S; Subbian S Front Mol Biosci; 2019; 6():105. PubMed ID: 31681793 [TBL] [Abstract][Full Text] [Related]
29. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Manca C; Tsenova L; Bergtold A; Freeman S; Tovey M; Musser JM; Barry CE; Freedman VH; Kaplan G Proc Natl Acad Sci U S A; 2001 May; 98(10):5752-7. PubMed ID: 11320211 [TBL] [Abstract][Full Text] [Related]
30. Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis. Bai X; Shang S; Henao-Tamayo M; Basaraba RJ; Ovrutsky AR; Matsuda JL; Takeda K; Chan MM; Dakhama A; Kinney WH; Trostel J; Bai A; Honda JR; Achcar R; Hartney J; Joosten LA; Kim SH; Orme I; Dinarello CA; Ordway DJ; Chan ED Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5111-6. PubMed ID: 25820174 [TBL] [Abstract][Full Text] [Related]
31. Dual RNA-Seq of Mtb-Infected Macrophages In Vivo Reveals Ontologically Distinct Host-Pathogen Interactions. Pisu D; Huang L; Grenier JK; Russell DG Cell Rep; 2020 Jan; 30(2):335-350.e4. PubMed ID: 31940480 [TBL] [Abstract][Full Text] [Related]
32. The role of lipid raft aggregation in the infection of type II pneumocytes by Mycobacterium tuberculosis. Fine-Coulson K; Reaves BJ; Karls RK; Quinn FD PLoS One; 2012; 7(9):e45028. PubMed ID: 23024786 [TBL] [Abstract][Full Text] [Related]
33. Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis. Nahid P; Jarlsberg LG; Kato-Maeda M; Segal MR; Osmond DH; Gagneux S; Dobos K; Gold M; Hopewell PC; Lewinsohn DM PLoS One; 2018; 13(5):e0195392. PubMed ID: 29787561 [TBL] [Abstract][Full Text] [Related]
34. Spontaneous latency in a rabbit model of pulmonary tuberculosis. Subbian S; Tsenova L; O'Brien P; Yang G; Kushner NL; Parsons S; Peixoto B; Fallows D; Kaplan G Am J Pathol; 2012 Nov; 181(5):1711-24. PubMed ID: 22960076 [TBL] [Abstract][Full Text] [Related]
35. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]
36. Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Cao R; To K; Kachour N; Beever A; Owens J; Sathananthan A; Singh P; Kolloli A; Subbian S; Venketaraman V Biomol Concepts; 2021 Jun; 12(1):46-54. PubMed ID: 34062056 [TBL] [Abstract][Full Text] [Related]
37. [Deletion-insertion differences between the genomes of Mycobacterium tuberculosis highly virulent strain HN878 and less virulent strain CDC1551]. Gvozdevskiĭ NA; Azhikina TL; Sverdlov ED Zh Mikrobiol Epidemiol Immunobiol; 2006; (1):10-5. PubMed ID: 16532633 [TBL] [Abstract][Full Text] [Related]
38. The Transcriptional Foundations of Sp110-mediated Macrophage (RAW264.7) Resistance to Mycobacterium tuberculosis H37Ra. Wu Y; Guo Z; Yao K; Miao Y; Liang S; Liu F; Wang Y; Zhang Y Sci Rep; 2016 Feb; 6():22041. PubMed ID: 26912204 [TBL] [Abstract][Full Text] [Related]
39. Unraveling methylation changes of host macrophages in Mycobacterium tuberculosis infection. Zheng L; Leung ET; Wong HK; Lui G; Lee N; To KF; Choy KW; Chan RC; Ip M Tuberculosis (Edinb); 2016 May; 98():139-48. PubMed ID: 27156630 [TBL] [Abstract][Full Text] [Related]